Clinical trial
Pregnancy Exposure Registry for Tysabri®
NCT00472992 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00472992 |
|---|---|
| Title | Pregnancy Exposure Registry for Tysabri® |
| Official title | TYSABRI® Pregnancy Exposure Registry |
| Lead sponsor | Biogen, Industry |
| Collaborators | Elan Pharmaceuticals Industry |
| Status | Completed |
| Study type | Observational [Patient Registry] |
| Conditions | Crohn's Disease, Prenatal Exposure, Multiple Sclerosis, Pregnancy |
| Enrollment | 376 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | May 14, 2007 |
| Last update posted | Aug 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: